Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer

The prognosis of early breast cancer is linked to clinic-pathological stage and the molecular characteristics of intrinsic tumor cells. In some patients, the amount and quality of tumor-infiltrating immune cells appear to affect long term outcome. We aimed to propose a new tool to estimate immune infiltrate, and link these factors to patient prognosis according to breast cancer molecular subtypes.We performed in silico analyses in more than 2800...